Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

1-25 of 138 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3 Next ...

Role of <sup>18</sup>F-FDG-PET/CT in the initial staging of very high-risk Ewing Sarcoma in a prospective multicentric Phase II Study: Is there still a place for bone marrow sampling?
Jehanno N, Corradini N, Gaspar N, Brahmi M, Valentin T, Revon Rivière G, Lervat C, Probert J, Entz-Werle N, Mansuy L, Plantaz D, Rios M, Saumet L, Verité C, Castex MP, Thebaud E, Cassou-Mounat T, Plissonnier AS, Mosseri V, [...] Laurence V
Br J Cancer, 131(10):1605-1612, 08 Oct 2024
Cited by: 0 articles | PMID: 39379569
Add to export list
Concurrent Olaparib and Radiotherapy in Patients With Triple-Negative Breast Cancer: The Phase 1 Olaparib and Radiation Therapy for Triple-Negative Breast Cancer Trial.
Loap P, Loirat D, Berger F, Rodrigues M, Bazire L, Pierga JY, Vincent-Salomon A, Laki F, Boudali L, Raizonville L, Mosseri V, Jochem A, Eeckhoutte A, Diallo M, Stern MH, Fourquet A, Kirova Y
JAMA Oncol, 8(12):1802-1808, 01 Dec 2022
Cited by: 18 articles | PMID: 36301572 | PMCID: PMC9614672
Add to export list Free full text in Europe PMC
SIOP PNET5 MB Trial: History and Concept of a Molecularly Stratified Clinical Trial of Risk-Adapted Therapies for Standard-Risk Medulloblastoma.
Mynarek M, Milde T, Padovani L, Janssens GO, Kwiecien R, Mosseri V, Clifford SC, Doz F, Rutkowski S
Cancers (Basel), 13(23):6077, 02 Dec 2021
Cited by: 18 articles | PMID: 34885186 | PMCID: PMC8657236
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
One-Year Toxicity Report of the RADIOPARP Phase I Trial Evaluating Olaparib With Radiotherapy for Triple Negative Breast Cancer.
Loap P, Loirat D, Berger F, Rodrigues M, Bazire L, Pierga JY, Ricci F, Cao KI, Vincent-Salomon A, Laki F, Ezzili C, Raizonville L, Mosseri V, Neffati S, Ezzalfani M, Fourquet A, Kirova Y
Int J Radiat Oncol Biol Phys, 111(3s):S8, 01 Nov 2021
Cited by: 0 articles | PMID: 34700637
Add to export list
Combination of Olaparib with radiotherapy for triple-negative breast cancers: One-year toxicity report of the RADIOPARP Phase I trial.
Loap P, Loirat D, Berger F, Cao K, Ricci F, Jochem A, Raizonville L, Mosseri V, Fourquet A, Kirova Y
Int J Cancer, 149(10):1828-1832, 26 Jul 2021
Cited by: 16 articles | PMID: 34270809
Add to export list
Clinical management of atypical ductal hyperplasia on vacuum-assisted biopsy of microcalcifications: External validation study of a decision tree selecting patients eligible for surveillance.
El Sanharawi I, Bataillon G, Journo G, Farkhondeh F, Sebbag-Sfez D, Malhaire C, Tardivon A, Mosseri V, Thibault FE
Eur J Radiol, 141:109826, 17 Jun 2021
Cited by: 1 article | PMID: 34174485
Add to export list
Combination of Olaparib and Radiation Therapy for Triple Negative Breast Cancer: Preliminary Results of the RADIOPARP Phase 1 Trial.
Loap P, Loirat D, Berger F, Ricci F, Vincent-Salomon A, Ezzili C, Mosseri V, Fourquet A, Ezzalfani M, Kirova Y
Int J Radiat Oncol Biol Phys, 109(2):436-440, 21 Sep 2020
Cited by: 21 articles | PMID: 32971187
Add to export list
Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group.
Ambros IM, Tonini GP, Pötschger U, Gross N, Mosseri V, Beiske K, Berbegall AP, Bénard J, Bown N, Caron H, Combaret V, Couturier J, Defferrari R, Delattre O, Jeison M, Kogner P, Lunec J, Marques B, Martinsson T, [...] Ambros PF
J Clin Oncol, 38(31):3685-3697, 09 Sep 2020
Cited by: 8 articles | PMID: 32903140 | PMCID: PMC7605396
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Genomic complexity in pediatric synovial sarcomas (Synobio study): the European pediatric soft tissue sarcoma group (EpSSG) experience.
Orbach D, Mosseri V, Pissaloux D, Pierron G, Brennan B, Ferrari A, Chibon F, Bisogno G, De Salvo GL, Chakiba C, Corradini N, Minard-Colin V, Kelsey A, Ranchère-Vince D
Cancer Med, 7(4):1384-1393, 13 Mar 2018
Cited by: 13 articles | PMID: 29533008 | PMCID: PMC5911585
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Radiogenomics of neuroblastomas: Relationships between imaging phenotypes, tumor genomic profile and survival.
Brisse HJ, Blanc T, Schleiermacher G, Mosseri V, Philippe-Chomette P, Janoueix-Lerosey I, Pierron G, Lapouble E, Peuchmaur M, Fréneaux P, Galmiche L, Algret N, Peycelon M, Michon J, Delattre O, Sarnacki S
PLoS One, 12(9):e0185190, 25 Sep 2017
Cited by: 20 articles | PMID: 28945781 | PMCID: PMC5612658
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
[Relapse after rhabdomyosarcoma in childhood and adolescence: Impact of an early detection on survival].
Mallebranche C, Carton M, Minard-Colin V, Desfachelle AS, Rome A, Brisse HJ, Mosseri V, Thébaud E, Pellier I, Boutroux H, Gandemer V, Corradini N, Orbach D
Bull Cancer, 104(7-8):625-635, 04 Jul 2017
Cited by: 3 articles | PMID: 28687117
Add to export list
[Care pathways before diagnosis in children and adolescents with malignancies].
Tatencloux S, Mosseri V, Papillard-Maréchal S, Mesples B, Pellegrino B, Belloy M, Jimènez I, Algret N, Levy D, Michon J, Orbach D
Bull Cancer, 104(2):128-138, 07 Dec 2016
Cited by: 3 articles | PMID: 27939009
Add to export list
Nonparameningeal head and neck rhabdomyosarcoma in children and adolescents: Lessons from the consecutive International Society of Pediatric Oncology Malignant Mesenchymal Tumor studies.
Orbach D, Mosseri V, Gallego S, Kelsey A, Devalck C, Brenann B, van Noesel MM, Bergeron C, Merks JH, Rechnitzer C, Jenney M, Minard-Colin V, Stevens M
Head Neck, 39(1):24-31, 26 Jul 2016
Cited by: 8 articles | PMID: 27459057
Add to export list
Ligand-receptor dissociated expression explains high TSLP without prognostic impact in human primary head and neck squamous cell carcinoma.
Guillot-Delost M, Guilleré L, Berger F, Ventre A, Michea P, Sirven P, Pattarini L, Scholer-Dahirel A, Kebir FZ, Huerre M, Chouchane-Mlik O, Lappartient E, Rodriguez J, Jouffroy T, Klijanienko J, Nicolas A, Sastre-Garau X, Honorio S, Mosseri V, [...] Soumelis V
Oncoimmunology, 5(7):e1179414, 07 Jun 2016
Cited by: 5 articles | PMID: 27622034 | PMCID: PMC5006899
Add to export list Free full text in Europe PMC
[Sophrology for patients in oncology].
Barré C, Falcou MC, Mosseri V, Carrié S, Dolbeault S
Soins, (800):17-20, 01 Nov 2015
Cited by: 1 article | PMID: 26567064
Add to export list
Relapse after localized rhabdomyosarcoma: Evaluation of the efficacy of second-line chemotherapy.
Winter S, Fasola S, Brisse H, Mosseri V, Orbach D
Pediatr Blood Cancer, 62(11):1935-1941, 06 Jul 2015
Cited by: 25 articles | PMID: 26150380
Add to export list
Mortality in Children with Optic Pathway Glioma Treated with Up-Front BB-SFOP Chemotherapy.
Rakotonjanahary J, De Carli E, Delion M, Kalifa C, Grill J, Doz F, Leblond P, Bertozzi AI, Rialland X, Brain Tumor Committee of SFCE
PLoS One, 10(6):e0127676, 22 Jun 2015
Cited by: 24 articles | PMID: 26098902 | PMCID: PMC4476571
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Outcome of oncoplastic breast-conserving surgery following bracketing wire localization for large breast cancer.
Malhaire C, Hequet D, Falcou MC, Feron JG, Tardivon A, Leduey A, Guillot E, Mosseri V, Rouzier R, Couturaud B, Reyal F
Breast, 24(4):370-375, 23 Apr 2015
Cited by: 5 articles | PMID: 25913288
Add to export list
Influence of image-defined risk factors on the outcome of patients with localised neuroblastoma. A report from the LNESG1 study of the European International Society of Paediatric Oncology Neuroblastoma Group.
Monclair T, Mosseri V, Cecchetto G, De Bernardi B, Michon J, Holmes K
Pediatr Blood Cancer, 62(9):1536-1542, 08 Feb 2015
Cited by: 33 articles | PMID: 25663103
Add to export list
Does aggressive local treatment have an impact on survival in children with metastatic rhabdomyosarcoma?
Ben Arush M, Minard-Colin V, Mosseri V, Defachelles AS, Bergeron C, Algret N, Fasola S, André N, Thebaud E, Corradini N, Bernier V, Martelli H, Ranchère D, Orbach D
Eur J Cancer, 51(2):193-201, 01 Dec 2014
Cited by: 17 articles | PMID: 25471261
Add to export list
Orbital rhabdomyosarcoma in children: a favorable primary suitable for a less-invasive treatment strategy.
Boutroux H, Cellier C, Mosseri V, Helfre S, Levy C, Desjardins L, Plancher C, Freneaux P, Michon J, Orbach D
J Pediatr Hematol Oncol, 36(8):605-612, 01 Nov 2014
Cited by: 6 articles | PMID: 25171453
Add to export list
Ewing-like sarcomas with BCOR-CCNB3 fusion transcript: a clinical, radiological and pathological retrospective study from the Société Française des Cancers de L'Enfant.
Cohen-Gogo S, Cellier C, Coindre JM, Mosseri V, Pierron G, Guillemet C, Italiano A, Brugières L, Orbach D, Laurence V, Delattre O, Michon J
Pediatr Blood Cancer, 61(12):2191-2198, 31 Aug 2014
Cited by: 53 articles | PMID: 25176412
Add to export list
Long-term evaluation of orbital rhabdomyosarcoma in children.
Boutroux H, Levy C, Mosseri V, Desjardins L, Plancher C, Helfre S, Freneaux P, Cellier C, Orbach D
Clin Exp Ophthalmol, 43(1):12-19, 20 Sep 2014
Cited by: 11 articles | PMID: 24923774
Add to export list
Clinical characteristics and outcome of patients with neuroblastoma presenting genomic amplification of loci other than MYCN.
Guimier A, Ferrand S, Pierron G, Couturier J, Janoueix-Lerosey I, Combaret V, Mosseri V, Thebaud E, Gambart M, Plantaz D, Marabelle A, Coze C, Rialland X, Fasola S, Lapouble E, Fréneaux P, Peuchmaur M, Michon J, Delattre O, Schleiermacher G
PLoS One, 9(7):e101990, 11 Jul 2014
Cited by: 11 articles | PMID: 25013904 | PMCID: PMC4094484
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Extensive pure ductal carcinoma in situ of the breast: identification of predictors of associated infiltrating carcinoma and lymph node metastasis before immediate reconstructive surgery.
Guillot E, Vaysse C, Goetgeluck J, Falcou MC, Couturaud B, Fitoussi A, Fourchotte V, Laki F, Malhaire C, Sigal-Zafrani B, Sastre-Garau X, Bollet MA, Mosseri V, Reyal F
Breast, 23(2):97-103, 31 Dec 2013
Cited by: 9 articles | PMID: 24388733
Add to export list

1-25 of 138 results

1 2 3 Next ...

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

Role of <sup>18</sup>F-FDG-PET/CT in the initial staging of very high-risk Ewing Sarcoma in a prospective multicentric Phase II Study: Is there still a place for bone marrow sampling?

Concurrent Olaparib and Radiotherapy in Patients With Triple-Negative Breast Cancer: The Phase 1 Olaparib and Radiation Therapy for Triple-Negative Breast Cancer Trial.

SIOP PNET5 MB Trial: History and Concept of a Molecularly Stratified Clinical Trial of Risk-Adapted Therapies for Standard-Risk Medulloblastoma.

One-Year Toxicity Report of the RADIOPARP Phase I Trial Evaluating Olaparib With Radiotherapy for Triple Negative Breast Cancer.

Combination of Olaparib with radiotherapy for triple-negative breast cancers: One-year toxicity report of the RADIOPARP Phase I trial.

Clinical management of atypical ductal hyperplasia on vacuum-assisted biopsy of microcalcifications: External validation study of a decision tree selecting patients eligible for surveillance.

Combination of Olaparib and Radiation Therapy for Triple Negative Breast Cancer: Preliminary Results of the RADIOPARP Phase 1 Trial.

Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group.

Genomic complexity in pediatric synovial sarcomas (Synobio study): the European pediatric soft tissue sarcoma group (EpSSG) experience.

Radiogenomics of neuroblastomas: Relationships between imaging phenotypes, tumor genomic profile and survival.

[Relapse after rhabdomyosarcoma in childhood and adolescence: Impact of an early detection on survival].

[Care pathways before diagnosis in children and adolescents with malignancies].

Nonparameningeal head and neck rhabdomyosarcoma in children and adolescents: Lessons from the consecutive International Society of Pediatric Oncology Malignant Mesenchymal Tumor studies.

Ligand-receptor dissociated expression explains high TSLP without prognostic impact in human primary head and neck squamous cell carcinoma.

[Sophrology for patients in oncology].

Relapse after localized rhabdomyosarcoma: Evaluation of the efficacy of second-line chemotherapy.

Mortality in Children with Optic Pathway Glioma Treated with Up-Front BB-SFOP Chemotherapy.

Outcome of oncoplastic breast-conserving surgery following bracketing wire localization for large breast cancer.

Influence of image-defined risk factors on the outcome of patients with localised neuroblastoma. A report from the LNESG1 study of the European International Society of Paediatric Oncology Neuroblastoma Group.

Does aggressive local treatment have an impact on survival in children with metastatic rhabdomyosarcoma?

Orbital rhabdomyosarcoma in children: a favorable primary suitable for a less-invasive treatment strategy.

Ewing-like sarcomas with BCOR-CCNB3 fusion transcript: a clinical, radiological and pathological retrospective study from the Société Française des Cancers de L'Enfant.

Long-term evaluation of orbital rhabdomyosarcoma in children.

Clinical characteristics and outcome of patients with neuroblastoma presenting genomic amplification of loci other than MYCN.

Extensive pure ductal carcinoma in situ of the breast: identification of predictors of associated infiltrating carcinoma and lymph node metastasis before immediate reconstructive surgery.

Partnerships & funding